Defender Capital, 13F annual report

Defender Capital, is an investment fund managing more than $293 billion ran by Grant Wilson. There are currently 35 companies in Mr. Wilson’s portfolio. The largest investments include Vanguard Short Term Treasury Etf Iv and Berkshire Hathaway, together worth $93.1 billion.

Limited to 30 biggest holdings

$293 billion Assets Under Management (AUM)

As of 22nd July 2024, Defender Capital,’s top holding is 900,319 shares of Vanguard Short Term Treasury Etf Iv currently worth over $52.2 billion and making up 17.8% of the portfolio value. In addition, the fund holds 100,530 shares of Berkshire Hathaway worth $40.9 billion, whose value grew 13.2% in the past six months. The third-largest holding is Danaher worth $33.8 billion and the next is Staar Surgical Co worth $30.9 billion, with 649,187 shares owned.

Currently, Defender Capital,'s portfolio is worth at least $293 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Defender Capital,

The Defender Capital, office and employees reside in Charlotte, North Carolina. According to the last 13-F report filed with the SEC, Grant Wilson serves as the Associate at Defender Capital,.

Recent trades

In the most recent 13F filing, Defender Capital, revealed that it had opened a new position in Dell Technologies Inc and bought 3,517 shares worth $485 million. This means they effectively own approximately 0.1% of the company. Dell Technologies Inc makes up 1.7% of the fund's Technology sector allocation and has decreased its share price by approximately 0.1% in the past year.

The investment fund also strengthened its position in Berkshire Hathaway by buying 1,656 additional shares. This makes their stake in Berkshire Hathaway total 100,530 shares worth $40.9 billion. Berkshire Hathaway dropped approximately 0.1% in the past year.

On the other hand, there are companies that Defender Capital, is getting rid of from its portfolio. Defender Capital, closed its position in Enovis Corporation on 29th July 2024. It sold the previously owned 7,500 shares for $468 million. Grant Wilson also disclosed a decreased stake in Vanguard Short Term Treasury Etf Iv by approximately 0.1%. This leaves the value of the investment at $52.2 billion and 900,319 shares.

One of the smaller hedge funds

The two most similar investment funds to Defender Capital, are Ug Investment Advisers and Pineridge Advisors. They manage $293 billion and $293 billion respectively.

Grant Wilson investment strategy

Defender Capital,’s portfolio is diversified across 9 sectors. Currently, their heaviest sector is Health Care — making up 22.3% of the total portfolio value. The fund focuses on investments in the United States as 60.0% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 54% of the total holdings value. On the other hand, small-cap stocks make up only 5.7% of the portfolio. The average market cap of the portfolio companies is close to $288 billion.

The complete list of Defender Capital, trades based on 13F SEC filings

These positions were updated on July 29th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security	Shares Owned	Value	Allocation
Vanguard Short Term Treasury Etf Iv	7.09% 900,319	$52,209,499,000	17.84%
Berkshire Hathaway Inc.	1.67% 100,530	$40,895,604,000	13.97%
Danaher Corp.	3.51% 135,187	$33,776,567,000	11.54%
Staar Surgical Co.	11.12% 649,187	$30,907,793,000	10.56%
Monster Beverage Corp.	14.78% 435,486	$21,752,526,000	7.43%
Palantir Technologies Inc.	28.44% 789,217	$19,990,867,000	6.83%
Fortive Corp	1.86% 234,166	$17,351,710,000	5.93%
Teledyne Technologies Inc	3.32% 40,206	$15,599,124,000	5.33%
Axon Enterpise Inc	5.52% 44,101	$12,976,278,000	4.43%
Veralto Corp	9.11% 123,125	$11,754,787,000	4.02%
Costco Whsl Corp	8.93% 12,754	$10,840,650,000	3.70%
Lineage Cell Therapeutics In	0.11% 4,972,975	$4,959,548,000	1.69%
Intel Corp.	0.44% 118,965	$3,684,346,000	1.26%
Esab Corporation	3.83% 23,881	$2,255,111,000	0.77%
NVIDIA Corp	900.93% 14,063	$1,737,343,000	0.59%
Chevron Corp.	162.85% 10,514	$1,644,600,000	0.56%
Apple Inc	62.66% 7,793	$1,641,256,000	0.56%
Amazon.com Inc.	60.36% 8,010	$1,547,933,000	0.53%
Microsoft Corporation	30.97% 3,396	$1,517,891,000	0.52%
Spdr Portfolio Sp 500 Etf	96.36% 10,800	$691,200,000	0.24%
Ishares Russell 2000 Etf	66.67% 3,000	$608,670,000	0.21%
Pfizer Inc.	0.11% 17,935	$501,821,000	0.17%
Dell Technologies Inc	Opened 3,517	$485,029,000	0.17%
Enovis Corporation	Closed 7,500	$468,375,000
Martin Marietta Matls Inc	No change 755	$409,059,000	0.14%
Jpmorgan Chase Co	No change 1,849	$373,979,000	0.13%
Arista Networks Inc	Opened 1,005	$352,232,000	0.12%
Ishares Core Sp 500 Etf	No change 600	$328,338,000	0.11%
JPMorgan Equity Premium Income	No change 5,625	$318,825,000	0.11%
Phillips 66	No change 2,073	$292,645,000	0.10%
Altria Group Inc.	No change 6,086	$277,217,000	0.09%
Taiwan Semiconductor Mfg Ltd	No change 1,509	$262,279,000	0.09%
Walt Disney Co (The)	Closed 2,013	$246,311,000
Synopsys, Inc.	Opened 402	$239,214,000	0.08%
CSX Corp.	No change 6,910	$231,140,000	0.08%
Cisco Sys Inc	Closed 4,046	$201,936,000
Johnson Johnson	Closed 1,271	$201,059,000
Oncocyte Corporation	1.19% 55,220	$162,899,000	0.06%
374water Inc	No change 93,000	$111,600,000	0.04%
No transactions found
Showing first 500 out of 39 holdings